Skip to content

HELP

Cybin, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$10.69
+1.33%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
89.48x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.23x
Price / sales
—
Price / cash flow
-5.11x

Enterprise value

Enterprise value
$614.8M
EV / sales
—
EV / EBITDA
-3.47x
EV / EBIT
-3.47x
Market cap
$781.0M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026